Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LASAK is a prominent European medical device company specializing in the development and manufacture of dental implants and bone regeneration materials. Founded in 1991 and based in Prague, Czech Republic, the company is recognized for its innovative research into bioactive materials and surface treatments for titanium implants. Their flagship products include the IMPLADENT dental implant system and the BERA-MED orthopedic system, both of which utilize the proprietary BIO-surface technology to enhance osseointegration. In addition to implants, LASAK produces synthetic bone grafting materials such as PORESORB-TCP and OSTEOCON for use in dentistry and maxillofacial surgery. The company maintains a strong commitment to scientific validation, collaborating extensively with academic institutions and clinical centers across Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LASAK.